Citation: Dk. Nagi et al., PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) ACTIVITY IS ELEVATED IN ASIANAND CAUCASIAN SUBJECTS WITH NON-INSULIN-DEPENDENT (TYPE-2) DIABETES BUT NOT IN THOSE WITH IMPAIRED GLUCOSE-TOLERANCE (IGT) OR NONDIABETIC ASIANS, Diabetic medicine, 13(1), 1996, pp. 59-64
Authors:
NAGI DK
KNOWLER WC
HANSON RL
ALI VM
YUDKIN JS
Citation: Dk. Nagi et al., PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) AND NON-INSULIN-DEPENDENT DIABETES IN PIMA-INDIANS, SOUTH ASIANS AND EUROPEANS - POPULATIONS AT VARYING RISK OF NIDDM AND CORONARY-ARTERY DISEASE, Thrombosis and haemostasis, 75(6), 1996, pp. 921-927
Citation: Dk. Nagi et al., HYPERINSULINEMIA IN NONDIABETIC ASIAN SUBJECTS USING SPECIFIC ASSAYS FOR INSULIN, INTACT PROINSULIN, AND DES-31,32-PROINSULIN, Diabetes care, 19(1), 1996, pp. 39-42
Citation: Kf. Zaidi et Js. Yudkin, CHARACTERISTICS OF THE SODIUM-HYDROGEN EXCHANGE IN NON-INSULIN-DEPENDENT DIABETIC-PATIENTS WITH MICROALBUMINURIA AND HYPERTENSION, Clinical science, 90(1), 1996, pp. 13-19
Authors:
PAPPAS S
DONOHUE SM
DENVER AE
MOHAMEDALI V
GOUBET S
YUDKIN JS
Citation: S. Pappas et al., GLUCOSE-INTOLERANCE IN THALASSEMIA MAJOR IS RELATED TO INSULIN-RESISTANCE AND HEPATIC-DYSFUNCTION, Metabolism, clinical and experimental, 45(5), 1996, pp. 652-657
Authors:
MCCORMACK LJ
NAGI DK
STICKLAND MH
MANSFIELD MW
MOHAMEDALI V
YUDKIN JS
KNOWLER WC
GRANT PJ
Citation: Lj. Mccormack et al., PROMOTER (4G 5G) PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENOTYPE IN PIMA-INDIANS - RELATIONSHIP TO PLASMINOGEN-ACTIVATOR INHIBITOR-1 LEVELS AND FEATURES OF THE INSULIN-RESISTANCE SYNDROME/, Diabetologia, 39(12), 1996, pp. 1512-1518
Citation: Js. Yudkin, ASSESSING THE EVIDENCE ON ASPIRIN IN DIABETES-MELLITUS - GEMINI OR LIBRA - LUMPING OR SPLITTING - SURROGATE OR HARD - LOW OR HIGH - INTERVENTIONIST OR NIHILIST, Diabetologia, 39(11), 1996, pp. 1407-1408
Authors:
NAGI DK
MCCORMACK LJ
MOHAMEDALI V
YUDKIN JS
GRANT PJ
KNOWLER WC
Citation: Dk. Nagi et al., PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) ACTIVIN, ITS PROMOTER (4G 5G)GENOTYPE AND DIABETIC-RETINOPATHY IN SUBJECTS WITH NIDDM/, Diabetologia, 39, 1996, pp. 94-94
Authors:
FOOT EA
WILLIAMS ZV
MOHAMEDALI V
YUDKIN JS
ECKLAND DJA
Citation: Ea. Foot et al., TROGLITAZONE BUT NOT GLIBENCLAMIDE REDUCES PROINSULIN-LIKE MOLECULES,RISK-FACTORS FOR CARDIOVASCULAR-DISEASE, IN NIDDM PATIENTS, Diabetologia, 39, 1996, pp. 256-256
Citation: V. Mohamedali et al., SIMPLE, SENSITIVE MICROPLATE IRMAS FOR INTACT AND DES-31,32-PROINSULIN COMPARED WITH HPLC AND CELLULOSE IRMAS, Clinical chemistry, 42(6), 1996, pp. 977-979
Authors:
FOYLE WJ
CARSTENSEN E
FERNANDEZ MC
YUDKIN JS
Citation: Wj. Foyle et al., LONGITUDINAL-STUDY OF ASSOCIATIONS OF MICROALBUMINURIA WITH THE INSULIN-RESISTANCE SYNDROME AND SODIUM-LITHIUM COUNTERTRANSPORT IN NONDIABETIC SUBJECTS, Arteriosclerosis, thrombosis, and vascular biology, 15(9), 1995, pp. 1330-1337
Authors:
PINKNEY JH
DENVER AE
MOHAMEDALI V
FOSTER C
YUDKIN JS
Citation: Jh. Pinkney et al., INSULIN-RESISTANCE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS IS ASSOCIATED WITH MICROALBUMINURIA INDEPENDENTLY OF AMBULATORY BLOOD-PRESSURE, Journal of diabetes and its complications, 9(4), 1995, pp. 230-233
Citation: Js. Yudkin, WHICH DIABETIC-PATIENTS SHOULD BE TAKING ASPIRIN - THOSE WITH VASCULAR-DISEASE AND THOSE AT GREATLY INCREASED RISK OF VASCULAR-DISEASE, BMJ. British medical journal, 311(7006), 1995, pp. 641-642
Citation: Js. Yudkin, CORONARY HEART-DISEASE IN DIABETES-MELLITUS - 3 NEW RISK-FACTORS AND A UNIFYING HYPOTHESIS, Journal of internal medicine, 238(1), 1995, pp. 21-30